Lessons from international experience in controlling pharmaceutical expenditure .3. Regulating industry

K Bloor; A Maynard; N Freemantle

Lessons from international experience in controlling pharmaceutical expenditure .3. Regulating industry

Health Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

This is the third of three papers that review international policies to control spending on drugs and to improve the efficiency of drug use. This paper reviews policies regulating the supply of drugs, particularly licensing and reimbursement controls, price and profit regulation. Price and profit controls contain few incentives for improving cost effective use of drugs, and focus on cost containment and profitability of domestic industry. Carefully monitored economic evaluation could lead to improvements in efficiency and benefits to patients and the health care system.

Original language	English
Pages (from-to)	33-35
Number of pages	5
Journal	British medical journal
Volume	313
Issue number	7048
Publication status	Published - 6 Jul 1996

Cite this

@article{74ca38b8f1394b12ba1c562086f8c0e9,

title = "Lessons from international experience in controlling pharmaceutical expenditure .3. Regulating industry",

abstract = "This is the third of three papers that review international policies to control spending on drugs and to improve the efficiency of drug use. This paper reviews policies regulating the supply of drugs, particularly licensing and reimbursement controls, price and profit regulation. Price and profit controls contain few incentives for improving cost effective use of drugs, and focus on cost containment and profitability of domestic industry. Carefully monitored economic evaluation could lead to improvements in efficiency and benefits to patients and the health care system.",

author = "K Bloor and A Maynard and N Freemantle",

year = "1996",

month = jul,

day = "6",

language = "English",

volume = "313",

pages = "33--35",

journal = "British medical journal",

issn = "0959-8138",

publisher = "BMJ",

number = "7048",

}

TY - JOUR

T1 - Lessons from international experience in controlling pharmaceutical expenditure .3. Regulating industry

AU - Bloor, K

AU - Maynard, A

AU - Freemantle, N

PY - 1996/7/6

Y1 - 1996/7/6

N2 - This is the third of three papers that review international policies to control spending on drugs and to improve the efficiency of drug use. This paper reviews policies regulating the supply of drugs, particularly licensing and reimbursement controls, price and profit regulation. Price and profit controls contain few incentives for improving cost effective use of drugs, and focus on cost containment and profitability of domestic industry. Carefully monitored economic evaluation could lead to improvements in efficiency and benefits to patients and the health care system.

AB - This is the third of three papers that review international policies to control spending on drugs and to improve the efficiency of drug use. This paper reviews policies regulating the supply of drugs, particularly licensing and reimbursement controls, price and profit regulation. Price and profit controls contain few incentives for improving cost effective use of drugs, and focus on cost containment and profitability of domestic industry. Carefully monitored economic evaluation could lead to improvements in efficiency and benefits to patients and the health care system.

M3 - Article

SN - 0959-8138

VL - 313

SP - 33

EP - 35

JO - British medical journal

JF - British medical journal

IS - 7048

ER -